155 related articles for article (PubMed ID: 12545030)
1. Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children.
Friedrich B; Schmidt R; Reiss I; Günther A; Seeger W; Müller M; Thul J; Schranz D; Gortner L
Crit Care Med; 2003 Jan; 31(1):284-90. PubMed ID: 12545030
[TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary bypass reduces pulmonary surfactant activity in infants.
Griese M; Wilnhammer C; Jansen S; Rinker C
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):237-44. PubMed ID: 10424996
[TBL] [Abstract][Full Text] [Related]
3. Cardiopulmonary bypass significantly reduces surfactant activity in children.
McGowan FX; Ikegami M; del Nido PJ; Motoyama EK; Kurland G; Davis PJ; Siewers RD
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):968-77. PubMed ID: 8246579
[TBL] [Abstract][Full Text] [Related]
4. Surfactant content in children with inflammatory lung disease.
LeVine AM; Lotze A; Stanley S; Stroud C; O'Donnell R; Whitsett J; Pollack MM
Crit Care Med; 1996 Jun; 24(6):1062-7. PubMed ID: 8681574
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A
Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999
[TBL] [Abstract][Full Text] [Related]
6. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.
Günther A; Schmidt R; Nix F; Yabut-Perez M; Guth C; Rosseau S; Siebert C; Grimminger F; Morr H; Velcovsky HG; Seeger W
Eur Respir J; 1999 Sep; 14(3):565-73. PubMed ID: 10543276
[TBL] [Abstract][Full Text] [Related]
7. Dysfunction of pulmonary surfactant in chronically ventilated premature infants.
Merrill JD; Ballard RA; Cnaan A; Hibbs AM; Godinez RI; Godinez MH; Truog WE; Ballard PL
Pediatr Res; 2004 Dec; 56(6):918-26. PubMed ID: 15496605
[TBL] [Abstract][Full Text] [Related]
8. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties.
Günther A; Schmidt R; Harodt J; Schmehl T; Walmrath D; Ruppert C; Grimminger F; Seeger W
Eur Respir J; 2002 May; 19(5):797-804. PubMed ID: 12030716
[TBL] [Abstract][Full Text] [Related]
9. P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant.
Atochina EN; Beers MF; Scanlon ST; Preston AM; Beck JM
Am J Physiol Lung Cell Mol Physiol; 2000 Mar; 278(3):L599-609. PubMed ID: 10710533
[TBL] [Abstract][Full Text] [Related]
10. Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates.
Veldhuizen RA; Inchley K; Hearn SA; Lewis JF; Possmayer F
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):141-7. PubMed ID: 8216208
[TBL] [Abstract][Full Text] [Related]
11. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis.
Meyer KC; Sharma A; Brown R; Weatherly M; Moya FR; Lewandoski J; Zimmerman JJ
Chest; 2000 Jul; 118(1):164-74. PubMed ID: 10893374
[TBL] [Abstract][Full Text] [Related]
12. Influence of the type of congenital heart defects on epithelial lining fluid composition in infants undergoing cardiac surgery with cardiopulmonary bypass.
Simonato M; Baritussio A; Carnielli VP; Vedovelli L; Falasco G; Salvagno M; Padalino M; Cogo P
Pediatr Res; 2018 Apr; 83(4):791-797. PubMed ID: 29281616
[TBL] [Abstract][Full Text] [Related]
13. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
[TBL] [Abstract][Full Text] [Related]
14. Surface film formation in vitro by infant and therapeutic surfactants: role of surfactant protein B.
Danhaive O; Chapin C; Horneman H; Cogo PE; Ballard PL
Pediatr Res; 2015 Feb; 77(2):340-6. PubMed ID: 25360829
[TBL] [Abstract][Full Text] [Related]
15. [The effects of cardiopulmonary bypass on pulmonary surfactant activity].
Xing Q; Zhang S; Chen Z
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):225-7. PubMed ID: 10072808
[TBL] [Abstract][Full Text] [Related]
16. Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates.
Griese M; Neumann M; von Bredow T; Schmidt R; Ratjen F
Eur Respir J; 2002 Nov; 20(5):1284-91. PubMed ID: 12449186
[TBL] [Abstract][Full Text] [Related]
17. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies.
Günther A; Schmidt R; Feustel A; Meier U; Pucker C; Ermert M; Seeger W
Am J Respir Crit Care Med; 1999 Jan; 159(1):244-51. PubMed ID: 9872845
[TBL] [Abstract][Full Text] [Related]
18. Alveolar type II cells, surfactant protein A (SP-A), and the phospholipid components of surfactant in acute silicosis in the rat.
Kawada H; Horiuchi T; Shannon JM; Kuroki Y; Voelker DR; Mason RJ
Am Rev Respir Dis; 1989 Aug; 140(2):460-70. PubMed ID: 2764382
[TBL] [Abstract][Full Text] [Related]
19. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.
Wang Z; Chang Y; Schwan AL; Notter RH
Am J Respir Cell Mol Biol; 2007 Oct; 37(4):387-94. PubMed ID: 17556674
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary surfactant in cystic fibrosis.
Griese M; Birrer P; Demirsoy A
Eur Respir J; 1997 Sep; 10(9):1983-8. PubMed ID: 9311489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
